Hospital de la Timone

Marseille 13385 Cedex 05

0 studies enrolling now · 7 studies all time

What they study most

Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme), Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas), Cohort 3a and 3b: Chondrosarcoma, Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma, Cohort 5a: Other Non-Central Nervous System Solid Tumors With IDH1 Mutations, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, Guillain-Barré Syndrome, Miller Fisher Syndrome, Muscular Diseases, Muscular Disorders, Atrophic, Muscular Dystrophies

Studies at this site

• Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC — Completed
• This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2 — Completed
• International Guillain-Barré Syndrome Outcome Study — Completed
• A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation — Completed
• Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease — Stopped early
• An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy — Stopped early
• Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) — Completed